Drug & supplement interaction

Tetrahydrocannabivarin (thcv) + Deucravacitinib

Deucravacitinib brand name: Sotyktu.

No Known Interaction
The bottom line No known interaction

We found no known interaction between Tetrahydrocannabivarin (thcv) and Deucravacitinib in our sources. Absence of a documented interaction is not the same as proven safety, and does not guarantee one does not exist. Do not start, stop, or change a medication or supplement based on this page; confirm with your pharmacist or doctor first.

Know someone taking this? Share
Interaction report

Tetrahydrocannabivarin (thcv) and Deucravacitinib

We checked these two against our interaction database. Here is what we found.

No Known Interaction Found

We did not find a documented interaction between Deucravacitinib and Tetrahydrocannabivarin (thcv) in our sources. This does not guarantee that the combination is completely free of risk — there is often limited research on supplements and herbal products, especially around drug interactions.

Worth understanding: our licensed dataset holds no drug-interaction record for Tetrahydrocannabivarin (thcv) at all — not against Deucravacitinib, and not against any other medication we track. This verdict therefore rests on the absence of any recorded data, not on research that looked at this combination and found nothing. We cannot rule an interaction out.

If you decide to take both, the practical routine is simple: add one new thing at a time and note the date you started it. If the combination is going to disagree with you, it usually shows in the first days to a couple of weeks — and a start date turns “I’ve been feeling off” into something a pharmacist can actually work with. Do not stop a prescribed medicine on your own.

Always talk with your pharmacist or doctor before making changes to your medications or supplements, particularly if you take several medications or have an ongoing health condition.

Tetrahydrocannabivarin (thcv) safety at a glance

Tetrahydrocannabiv... overall Use caution Human safety data are limited, and product quality and legality vary a lot.
Pregnancy Avoid Cannabis-derived compounds are not considered safe in pregnancy.
Breastfeeding Avoid Cannabinoids can pass into breast milk, so avoid use while nursing.

Safety guidance is general; always confirm with your pharmacist or doctor for your situation.

Still wondering about combining Deucravacitinib and Tetrahydrocannabivarin (thcv)? Ask Dr. Brian Staiger, PharmD, BCPS directly ›
What to actually watch for

What Deucravacitinib’s Own FDA Label Lists

This is not an interaction — none of it involves Tetrahydrocannabivarin (thcv). These are the most notable effects listed in the ADVERSE REACTIONS section of Deucravacitinib’s own FDA label, for the medication by itself. Knowing the drug’s own list makes it easier to work out the likely cause if something new turns up while you take both. 4 of them are worth acting on rather than waiting out — marked below.

  • Severe muscle breakdown Worth acting on
  • Kidney problems Worth acting on
  • Liver problems Worth acting on
  • A higher chance of infection Worth acting on
  • Acne mentioned in 8.7% of FDA reports for Deucravacitinib
  • Mouth irritation or sores
  • A stuffy or runny nose
  • Sore throat
  • Joint pain
  • A skin rash mentioned in 7.0% of FDA reports for Deucravacitinib

From the ADVERSE REACTIONS section of the FDA label for Deucravacitinib. Read the label on DailyMed › Where a percentage is shown, it is the share of 2,800 voluntary FDA FAERS reports for Deucravacitinib that mention that effect — a reporting proportion, not an incidence rate and not evidence the drug caused it. Tetrahydrocannabivarin (thcv)’s licensed record lists no adverse effects our clinical vocabulary could match, so there is no Tetrahydrocannabivarin (thcv) side to compare — that is a limit of the record, not a statement that Tetrahydrocannabivarin (thcv) has no side effects.

Everything else you take

See Every Supplement That Interacts With Deucravacitinib

This page covers Tetrahydrocannabivarin (thcv) only. If you take other supplements — a multivitamin, a sleep aid, something for joints — the Deucravacitinib page lists 106 supplements it has a documented interaction with, worst first, each one explained.

The most serious there right now: Activated Charcoal (major), Beer (major), Siberian Cocklebur (major), Wine (major) and Active Hexose Correlated Compound (ahcc) (moderate).

By severity: 4 major · 92 moderate · 10 minor.

From our pharmacist’s overview on the Deucravacitinib page

“Deucravacitinib (Sotyktu) calms an overactive immune system to treat plaque psoriasis, which is exactly why its 106 supplement interactions deserve genuine respect. The biggest group, 53 ingredients, may stimulate immune function and could blunt the drug's benefit.”

Reviewed by 2 · Jul 18, 2026

Open the Deucravacitinib interaction page

How much people look this up

Where Tetrahydrocannabivarin (thcv) and Deucravacitinib Sit Against Everything Else

Out of every supplement and medication people look up on HelloPharmacist, here is where these two land this week — and which way each has been moving.

Supplement Tetrahydrocannabivarin (thcv)
Steady interest

#945 of 1,452 supplements looked up here in the last 7 days

29 days ago today
Medication Deucravacitinib
Steady interest

#1,461 of 2,830 medications looked up here in the last 7 days

29 days ago today

Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is. A supplement can climb this list because of a news story. It counts every request to the page, automated ones included, and nothing here identifies anyone.

Where does our data come from?
  • Source: the Natural Medicines (TRC Healthcare) clinical database — the evidence-graded professional reference for herb & supplement interactions. Tetrahydrocannabivarin (thcv) is not yet covered by that licensed database, so its write-up cites publicly available medical sources directly (see the references below).
  • Citation library: 103,510 references behind our interaction content, 65,311 of them resolved to verified PubMed/DOI sources. See every Tetrahydrocannabivarin (thcv) reference on this page ↓
  • Freshness: we automatically re-check this combination every week — this pair was last verified September 13, 2026. The Tetrahydrocannabivarin (thcv) and Deucravacitinib records this page draws on were last updated June 22, 2026.
  • What “no known interaction” means: no documented interaction in the sources above — not a guarantee of safety. Supplements are studied far less than prescription drugs, so we say exactly what the evidence supports, and nothing more.
Data structure & sourcing designed and verified by .
Supplement

About Tetrahydrocannabivarin (thcv)

What is Tetrahydrocannabivarin (thcv)?

  • Appetite control and weight management
  • Blood sugar support
  • Energy and focus
  • General wellness

Tetrahydrocannabivarin (THCV) is a minor cannabinoid found in cannabis that is being studied for appetite, metabolism, and blood sugar, but human evidence is very limited. Product quality, legal status, and dosing vary widely, so talk with your pharmacist or doctor before trying it, and avoid it during pregnancy and breastfeeding.

Cannabis sativa · Cannabaceae · Flowers and leaves of the cannabis plant (THCV is an extracted or isolated cannabinoid) · Oils, tinctures, capsules, gummies, vape products, and isolated extracts

An interaction check asks whether these two react with each other — it does not ask whether Tetrahydrocannabivarin (thcv) is a good idea for someone in your situation. Here is what our Tetrahydrocannabivarin (thcv) record says about it on its own.

Tetrahydrocannabivarin (thcv): dosing

There is no established standard dose for THCV. Research is too limited to recommend a specific milligram amount, and effects may even differ between low and high doses.If you choose to try a product, follow the directions on the label and start with the lowest amount.

From our Tetrahydrocannabivarin (thcv) monograph — the full record covers uses, side effects and every documented interaction.

Read the full Tetrahydrocannabivarin (thcv) monograph & all interactions
Medication

About Deucravacitinib

What Is Deucravacitinib Used For?

Brand name: Sotyktu

Sotyktu (deucravacitinib) is approved to treat two conditions in adults. First, it treats moderate-to-severe plaque psoriasis in people who are candidates for systemic (body-wide) therapy or phototherapy (light therapy). It is not recommended to combine Sotyktu with other strong immune-suppressing medications for this use.

Second, Sotyktu is approved to treat active psoriatic arthritis in adults.

Most-Reported Side Effects for Deucravacitinib

From FAERS, the FDA’s public side-effect reporting system (2,800 reports, all brands). Reports are voluntary and are not proof the drug caused the effect.

Acne 243 reports
Pruritus 226 reports
Rash 195 reports
Psoriasis 174 reports
Erythema 153 reports
See full Deucravacitinib drug information
Keep checking

Other Drugs & Tetrahydrocannabivarin (thcv)

Browse every other medication we’ve checked against Tetrahydrocannabivarin (thcv) — both the ones with a known interaction and the ones without. Select any drug for the full detail.

0Major
0Moderate
0Minor
2,829No known interaction
No interaction 2,829 drugs checked — show the list
Evidence & sources

Tetrahydrocannabivarin (thcv) References

The 2 sources that drive our Tetrahydrocannabivarin (thcv) monograph — publicly available pages from reputable medical and government organizations. Every link was verified to work before publishing. Tetrahydrocannabivarin (thcv) is not covered by the licensed Natural Medicines interaction database, so its page cites these public sources directly.

  1. Cannabis (Marijuana) and Cannabinoids: What You Need To Know — NIH NCCIH Source
  2. Marijuana — MedlinePlus Source

Medication overviews come from MedlinePlus (NIH); supplement label data from the NIH Dietary Supplement Label Database. Content is written and reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.

Pharmacist Counseling Corner

Taking Tetrahydrocannabivarin (thcv) and Deucravacitinib Together: Common Questions

Is it safe to take Tetrahydrocannabivarin (thcv) with Deucravacitinib?
We do not list a known interaction between Tetrahydrocannabivarin (thcv) and Deucravacitinib. That does not guarantee the combination is risk-free, so confirm with your pharmacist or doctor — especially if you take other medications or have a health condition.
Does Deucravacitinib interact with any supplements?
Yes. Deucravacitinib has documented interactions with 106 supplements in our database — Tetrahydrocannabivarin (thcv) is not one of them. The Deucravacitinib interaction page linked on this page lists every one, ranked by severity.

Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy

Still Have a Question About Deucravacitinib and Tetrahydrocannabivarin (thcv)?

Our pharmacists answer your medication & supplement questions — free.

Ask a pharmacist

This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.